A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study. According to this team's work, neurofilament light chain (NfL) has great potential as a biomarker for early detection of Alzheimer's disease and could be also useful for monitoring treatment response for that condition.
source https://www.pharmatutor.org/pharma-news/2020/new-evidence-for-a-blood-based-biomarker-for-alzheimer-disease
No comments:
Post a Comment